Introduction {#S1}
============

Adaptation to an extreme environment such as long-term isolation during a human spaceflight, represents a formidable medical challenge, but it provides a unique platform for investigating human adaptation to extreme environmental changes. Mars-500, a precursor to a planned mission to Mars and the longest space flight-related isolation experiment by far, was conducted partially to collect psychological and physiological data for the effects of a long-term deep space mission (see Materials and Methods). Previously, analyses from the collected data have reported that several aspects of human health could be disturbed during a long-term isolation environment, including psychiatric disorders ([@B37]), circadian disruptions ([@B2]), temporal dynamics of gut microbiota ([@B36]), immune responses ([@B40]), and physical-activity-related neuromuscular performance ([@B3]), suggesting that human health was disturbed at multiple phenotypic aspects during the mission. However, the mechanisms underlying these disturbances were poorly explored, and the association between different aspects of the health outcome underlying adaptation to prolonged isolation and a confined environment remains to be determined.

The ability of environmental factors to shape human health involves epigenetic mechanisms that mediate gene-environment interactions. DNA methylation, comprising the heritable changes in gene structure and function that occur without a change in the nucleotide sequence, is one of the most intensively studied epigenetic modifications in mammals ([@B5]). Since the association between genome-wide DNA methylation and phenotype has been reported in population cohorts ([@B30]; [@B28]; [@B9]), twins studies ([@B21]; [@B15]; [@B41]) and cell studies ([@B20]; [@B44]; [@B38])\_ENREF_10, DNA methylation might be a linking mechanism which explains the involvement of environmental factors between the human genome and health outcomes. Moreover, "Longitudinal" or "temporal" factors have been reported as important factors which could drift methylation variations ([@B10]; [@B31]; [@B33]; [@B11]; [@B24]; [@B22]). It is reasonable to hypothesize that epigenetic profiles (like DNA methylation) could drift during longitudinal confinement during the Mars 500 mission, and the DNA methylation change could be associated with different aspects of phenotype variations (such as physiological and psychological regulation).

In this study, as part of the Mars-500 project, we conducted a personalized dynamic interrogation of genome-wide DNA methylation profiling of six subjects at six sampling points during the simulation. Simultaneously, we measured mood state and plasma metabolic traits to investigate Psycho-Epigenome-Metabolism changes during adaptation to long term isolation. Intriguingly, we developed a PeSa algorithm to explore glucose and mood-state-synchronized DNA methylation sites, focusing on finding the dynamic associations between epigenetic patterns and phenotypes in each individual, and exploring the underling epigenetic connections between glucose and mood-state disturbances. Our data revealed individualized glucose-synchronized and mood-state-synchronized DNA methylation sites, and PTPRN2 was found to be associated with both glucose and mood state disturbances across all six subjects. It suggests that personalized phenotype-synchronized epigenetic features could reflect the effects on the human body, including the disturbances of glucose and mood states.

Materials and Methods {#S2}
=====================

Mission Background {#S2.SS1}
------------------

The Mars-500 project was conducted by the Institute of Biomedical Problems (IBMP) of the Russian Academy of Sciences (RAS) in Moscow and was aimed at simulating an interplanetary manned flight, with a particular focus on the health and working capacity of the crew members. The data collected in this study focuses on the changes observed during the three stages of simulated flight (flight to, landing at, and return from Mars). The six-member crew consisted of three Russians, one Italian, one French and one Chinese individual. All the scientific experiments, including this study protocol, were reviewed and approved by the IBMP committee on Bioethics. Before participation, all six crew members underwent a thorough clinical examination and signed an informed consent form for the long-term isolation and confinement experiment. At the beginning of the simulation experiment, the age of the crew was 32.7 ± 4.7 (range 27∼38 years) and body weight was 83.4 ± 9.2 kg (range 73.5∼99.5).

The isolation facility for the simulation experiment was located at IBMP in Moscow, Russia. The isolation facility, as well as the operation rooms, technical facilities and offices, so that the simulated space flight mission could be contained in a single building at the institute. The periods of the virtual flight to Mars throughout the 520-days of isolation were as follows.

1.  *Period 1:* 1--11 days -- flight along a spiral path in the gravitational field of Earth.

2.  *Period 2:* 51--204 days -- flight on a heliocentric trajectory to Mars.

3.  *Period 3:* 205--243 days -- flight along a spiral path in the gravitational field of Mars ("twist").

4.  *Period 4:* 244--272 days -- flight in Mars' orbit with descent of the 111 takeoff and landing module on the planet surface and returning to the Martian expeditionary facility. In this period a simulation of three trips with two subjects to the surface of Mars was carried out. At this time three crew members rested in the model of the Martian orbital facility observing and communicating with the crew of the takeoff and landing module.

5.  *Period 5:* 273--309 days -- flight along a spiral path in the gravitational field of Mars ("spin up").

6.  *Period 6:* 310--467 days -- flight on a heliocentric trajectory up to the vicinity of Earth.

7.  *Period 7:* 468--520 days -- flight along a spiral path in the Earth's gravitational field.

Food was primarily provided by companies or agencies from Russia, Europe, Korea, and China. Nutrients in the food met the recommended criteria of the World Health Organization and the Russian and American standards for crew members in the International Space Station. Food during the first half of the mission (+1 day∼+250 days) included frozen foods (56 out of 111 types of food) while the second half of the mission (+250 days∼+520d) consisted mainly of dry foods, and there were also small differences in the food providers, e.g., the food during the first half of the mission contained a certain proportion of European food, while the food during the second half of the mission included some Korean and Chinese food. During the 30 days of the simulated landing period, some crew members, including one Russian, one Italian and one Chinese member shared the diet for the landing mission, which was different than that of the other three crew members. Considering the necessary nutritional intake, all Mars500 crewmembers had three meals each day according to the arranged daily menu, which was recycled every 7 days for the first half of the mission and every 5 days for the second half of the mission.

Biochemical and Epigenetic Assay {#S2.SS2}
--------------------------------

Peripheral whole blood cells were extracted from all six crew members before breakfast on −7, +60(+61), +120(+121), +168(+169), +249(+250), +300(+301), +360(+361), +418(+419), +510(+511), and +527 days. For each blood extraction procedure, all six crew members were equally and randomly divided into two groups on two consecutive days, respectively. The day given in brackets represents the day for the second group for each sampling event. After extraction, whole blood cells were immediately treated with EDTA anticoagulation, transferred outside of the module and centrifuged (at 3,000 rpm for 15 min at 4°C) to isolate the plasma from blood cells. Plasma parameters concentrations or counts were assayed with enzyme-linked immunosorbent assay (ELISA) kits (R&B, United States), or radio-immunological assay (RIA) kits (R&B, United States) according to the manufacturer's instructions. DNA Methylation profiling for the blood cells were also determined using the Illumina 450k platform, and characterization of the dynamic variations in the blood cell methylome were clustered and depicted.

DNA was extracted from frozen blood samples by standard proteinase K/RNase treatment and phenol/chloroform extraction. Bisulfite modification of DNA (≥500 ng for each sample) was conducted using an EZ DNA Methylation Kit (Zymo Research) according to the manufacturer's procedure. The Infinium Methylation 450K assay was performed according to Illumina's standard protocol.

HM450K Data Preprocessing {#S2.SS3}
-------------------------

Raw intensity data (IDAT) files were imported into the R environment (version 3.4.1) and processed using the ChAMP and minfi package. All analyses were performed in R using packages available from the Bioconductor project. Probes were then removed in data preprocessing: ([@B37]) probes with a bead-count \<3 in at least 5% of samples, ([@B2]) non-cg probes, ([@B36]) probes with SNPs, ([@B40]) probes that align to multiple locations. Probes on the X and Y chromosomes were kept since all the subjects are male. Following this, a final data set of 412,413 probes and 37 samples (six sampling points for six subjects, and one replicate sample) remained for downstream analysis.

Analysis of Biochemical Indicators {#S2.SS4}
----------------------------------

Repeated Measures Analysis was used to find significant changes in all indicators in this study, which is considered to be typical longitudinal data from factorial experiments. We applied a parametric method (i.e., ANOVA) to determine significance. Additionally, considering the small sample size in this study and the restrictive distributional assumptions for the use of parametric and semiparametric procedures, we also employed non-parametric rank-based methods (i.e., nparLD test, which stands for "Non-parametric Analysis of Longitudinal Data"), which is robust to outliers and exhibits competitive performance ([@B26]). For a specific indicator, the output of the ANOVA or nparLD test was a p-value, and an indicator was defined as significantly changed across all the sampling points during the mission if the *p* -value \< 0.05 (ANOVA or nparLD test). The ANOVA test was performed by R package "stats" (version 3.1.1). The nparLD test was performed by R package "nparLD" (version 2.1), and the ANOVA-type *p* -value was taken.

Algorithm of PeSa Analysis {#S2.SS5}
--------------------------

Considering the longitudinal time-course of the data in the 520-day simulated flight mission, for PeSa analysis between indicators, we not only considered the traditional Pearson correlation across all sampling points, but also the similarity of the time-course curve shape by a slope-correlation, which applies the Pearson correlation to the time-course gradient of indicators. The slope correlation analysis highlights the time-course synchronization or variation amongst indicators. For a correlation between time-course indicator ***A*** = (a~1~, a~2~, ..., a~i~) and ***B*** = (b~1~, b~2~, ..., b~i~), where *i* is the number of sampling points, the slope correlation is performed as follows:

1.  *P* -value~Corr~(***A, B***) was generated by Pearson correlation(***A, B***)

2.  ***A***^\*^ = *(a~2~,a~3~, ..., a~i~)- (a~1~, a~2~, ..., a~i--1~)*, and ***B***^\*^ = *(b~2~, b~3~, ..., b~i~) - (b~1~, b~2~, ..., b~i--1~)*

3.  *P* -value~Slope--corr~(***A, B***) was generated by Pearson correlation(***A***^\*^, ***B***^\*^)

4.  indicator ***A*** and ***B*** was defined as significantly synchronization if *P* -value~Corr~(***A, B***) \< 0.05 and *P* -value~Slope--corr~(***A, B***).

Analysis of Mood States {#S2.SS6}
-----------------------

The Profile of Mood States is a specific psychological questionnaire ([@B19]; [@B39]; [@B37]) and has been widely used to assess transient and distinct mood states in a range of different research studies, such as evaluation of individuals' psychological conditions for occupational health and safety or under extreme environments (e.g., the expedition in Antarctic exploration; [@B19]; [@B39]; [@B37]). It consists of 65 adjectives that are rated by subjects on a 5-point scale (1 = lowest level, 5 = highest level). Six factors have been derived from this test, including TA, DD, FI, AH, CB, and VA.

This test was manipulated on a 14-in Lenovo laptop (1280^\*^800 pixels) during confinement. Each crewmember had a unique ID and password to run this program. At the beginning of the test, the instructions were provided in three languages (English, Russian, and Chinese), the crewmembers could then begin the test. When the crewmembers completed all 65 ratings, the data were automatically exported into a zip file with the crewmember's ID and the testing date (e.g., 5001_20100605.zip)

The standard Total Mood Disturbance (TMD) score was defined as follows.

$${TMD} = {{{TA} + {DD} + {AH} + {FI} + {CB}} - {VA}}$$

VA: Vigor-Activity; TA: Tension-Anxiety; DD: Depression-Dejection; AH: Anger-Hostility; FI: Fatigue-Inertia; CB: Confusion-Bewilderment.

Results {#S3}
=======

Data Design {#S3.SS1}
-----------

Over the course of this 520 days mission, we conducted personalized longitudinal DNA methylation patterns of peripheral whole blood cell profiling of six subjects across six sampling points. Multiple sampling points correspondingly synchronized with DNA methylation profiling were assigned to characterize three categories of parameters related to nutrient metabolism, stress and immunology (10 sampling points, covering six sampling points of DNA methylation profiling). Additionally, POMS scores (14 sampling points, covering six sampling points of DNA methylation profiling) were detected to investigate mood state variation during the mission ([Figure 1](#F1){ref-type="fig"}).

![Testing schedule of simulation experiment and biochemical changes in the MARS500 mission. Schematic diagram of the Mars-500 simulation space flight mission. Vertical arrowheads represent the time points of data sampling points, which are distributed over the whole flight mission. Colored triangles showed the testing time points for psychology, plasma biochemistry and blood cell DNA methylation profiling, respectively. The timepoints occupy the whole simulation process from pre-isolation, during isolation (traveling to Mars, landing on Mars and returning back to earth) and post-isolation phases.](fphys-10-00932-g001){#F1}

DNA Methylation Data Pre-processing {#S3.SS2}
-----------------------------------

We interrogated the genome-wide DNA methylation profile using the Illumina HumanMethylation450 BeadChip (450k), which covers more than 480,000 methylation sites in the genome. The signal was represented as a beta value normalized by the Funnorm method implemented in the R package *ChAMP* and *minfi*, and batch effect was corrected by ComBat method in R package *sva* ([@B18]; [@B1]; [@B23]) \_ENREF_15. Sample quality control was performed by R package *MethylAid*. Stringent quality control steps to assess probe performance (see Materials and Methods). Since many EWAS aim to identify associations between methylation and diseases or environmental factors that have relatively small effects on the methylome (\<10%), unwanted variation can be a significant problem for such studies, particularly when the number of samples is not large. To minimize the technical error and to validate its influence on biological variation, we performed replicate DNA methylation for one sample. Finally, 37 samples with data from 412,413 probes were remained for downstream analysis.

We performed replication hybridizations for one pair of the replication samples to assess sensitivity to detect biological variability across all sampling points versus technical variation. Biological variation was represented by sd~personal~(β) (standard-deviation of β-value across sampling points for each subjects) and range~personal~(β) (range of β-value across sampling points for each subjects). Technical variation was represented by an error(β) between one pair of replicates. For all pre-filtered probes, \>75% probes have an error(β) less than 0.008, compared with that, \>50% of probes have an sd~personal~(β) more than 0.012 and \>75% of probes have a range~personal~(β) more than 0.016 ([Supplementary Figure S1](#SM1){ref-type="supplementary-material"}). Results showed that, though the effect on the epigenome is relatively small, the majority of the pre-filtered probes have biological variation beyond technical variation.

DMPs Identification Across the Mission {#S3.SS3}
--------------------------------------

To identify "truly" differential DNA methylation sites across the experiment, we added a further stringent cutoff of a sd~personal~(β) \> 0.02 for all subjects in filtered probes with methylation drift far exceeding the mean error in this study. We then applied a parametric repeated measure analysis method (i.e., ANOVA) to find DMPs (differentially methylated-probes). Additionally, considering the small sample sizes in this study and the restrictive distributional assumptions for use of parametric and semiparametric procedures, we also employed non-parametric rank-based methods (i.e., nparLD test), which is robust to outliers and exhibits competitive performance. Exact 5326 DMPs were significantly changed (ANOVA fdr \< 0.05, and nparLD test fdr \< 0.05) ([Figure 2A](#F2){ref-type="fig"}). Functional annotation of the DMP-associated genes was analyzed by DAVID (v6.8) ([@B12],[@B13]). Results show that DMP-associated genes over-represented in platelet activation, circadian entrainment and the glucose metabolism-related pathway ([Table 1](#T1){ref-type="table"} and [Supplementary Tables S1--S6](#SM2){ref-type="supplementary-material"}). In order to characterize whether DMPs were more likely to occur at specific regions in the genome, we calculated the observed/expected frequency (enrichment) of gene-related and CGI-related locations annotated in the HM450 manifest and assigned *P* -values with hypergeometric tests. The 1stExon, 3′UTR, 5′UTR, TSS1500, TSS200 and CpG-Island regions showed significantly depletion in the DMPs dataset during the mission ([Figures 2B,C](#F2){ref-type="fig"}).

![DNA methylation changes in the MARS500 mission. **(A)** Heatmap of 5326 DMPs in this study. **(B)** Enrichment of DMPs (differentially methylated-probes during the mission) by genomic location. Log-fold difference of enrichment (observed/expected frequency) in the 5326 DMPs \[ANOVA fdr \< 0.05, nparLD test fdr \< 0.05, and personal sd(β) \> 0.02\] for specific genomic locations, grouped by association with genes. Pink bar indicates enrichment and light blue bar indicate depletion in the DMPs dataset. *P* -values. ^∗∗^*P* \< 1 × 10--20, ^∗∗∗^*P* \< 1 × 10--50. **(C)** as in **(B)**, 5326 DMPs for specific genomic locations, grouped by association with CGI. Pink bar indicates enrichment and light blue bar indicate depletion in the DMPs dataset.](fphys-10-00932-g002){#F2}

###### 

KEGG pathway enrichment analysis for DMPs in the MARS500 mission.

  **KEGG pathway**                     **FDR \< 0.05**   **FDR \< 0.05**                                                     
  ------------------------------------ ----------------- ----------------- -------------- ---------------- ----------------- ----------------
  hsa04611:Platelet activation         3.5e-2 (0.567)    --                --             3.7e-2 (0.47)    --                --
  hsa04930:Type II diabetes mellitus   2.1e-2 (0.547)    7e-3 (0.13)       1e-2 (0.107)   --               2.5e-2 (0.28)     1e-2 (0.149)
  hsa04911:Insulin secretion           --                2e-3 (0.077)      4e-4 (0.014)   --               3.91e-3 (0.098)   1.2e-2 (0.268)
  hsa04931:Insulin resistance          --                --                --             1.2e-2 (0.268)   3.3e-2 (0.267)    --
  hsa04713:Circadian entrainment       --                3e-3 (0.07)       7e-4 (0.023)   --               --                --
  hsa04730:Long-term depression        --                1.2e-2 (0.176)    --             --               --                --

Significance of pathway enrichment was shown as "

p

-value (Benjamini)" in this table. For full analysis, see

Supplementary Tables S1

--

S6

.

Phenotypes Change Across the Mission {#S3.SS4}
------------------------------------

The 46 blood biochemical indicators were assayed across the mission, which could be broadly grouped into three categories, related to nutrient metabolism, stress and immunology. In the DMPs identification, we applied both parametric and non-parametric repeated measures analysis, and found 18 indicators significantly changed across the mission (ANOVA *P* \< 0.05, and nparLD test *P* \< 0.05) ([Figure 3A](#F3){ref-type="fig"}). Fasting blood glucose, the most significantly changed one, showed a 3-stage stepwise raising trend ([Figure 3B](#F3){ref-type="fig"}). Following the initial average levels of 4.5 ± 0.34 mmol/L recorded before the missions start (Day-7), blood glucose levels remained stable until Day-168. After this, elevated glucose levels emerged with average levels reaching 5.2 ± 0.37 mmol/L, and within the final stage the average glucose levels reached 6.0 ± 0.37 mmol/L at Day-418. In particular, one subject exceeded 6.1 mmol/L, which is the limit for the clinical diagnostic standard for IFG, more commonly known as pre-diabetes. Glucose-related biochemical parameters such as 5-HT ([Figure 3C](#F3){ref-type="fig"}), NE, and cortisol, though significantly changed across the mission, showed no evidence for similar glucose step-wised profiles ([Supplementary Figures S2, S3](#SM1){ref-type="supplementary-material"}). Nevertheless, other glucose-related biochemical parameters such as insulin, C-peptide, ADI, were not significantly changed. Additionally, considering that mood state and BMI (Body Mass Index) are also associated with glucose metabolism, we tracked the POMS (14 sampling points) and BMI scores (20 sampling points). Results showed that no significant changes were found in POMS-TMD and BMI score ([Supplementary Figures S4, S5](#SM1){ref-type="supplementary-material"}).

![Biochemical changes in the MARS500 mission. **(A)** Significance of Biochemical indicator change during the mission. 18 indicators (orange bar) significantly changed (*P* \< 0.05, ANOVA). **(B)** Glucose dynamic change pattern during the mission. Bold black line: mean value of subjects at each sampling points. Colored dash line, glucose trend for each subject. **(C)** 5-HT dynamic change pattern during the mission. Bold black line: mean value of subjects at each sampling points. Colored dash line, 5-HT trend for each subject.](fphys-10-00932-g003){#F3}

Phenotype-Synchronized Methylation Sites {#S3.SS5}
----------------------------------------

From the above DNA methylation clustering results, we found that individual difference is an important factor and cannot be ignored when finding phenotype-associated epigenetic features in this study. We developed a PeSa algorithm to explore phenotype-synchronized changed DNA methylation sites ([Figure 4A](#F4){ref-type="fig"}, Materials and Methods). By applying this method, we could find the dynamic associations between epigenetic and phenotypes in individual perspectives. In PeSa analysis, we considered not only the traditional Pearson correlation between phenotypes and epigenetics across all sampling points, but also the similarity of the time-course curve shape by a slope-correlation, which applies the Pearson correlation to the time-course gradient of indicators. In this criterium, we found "strictly" synchronized DNA methylation sites for specific phenotypes. To extend the scanning range in the epigenome, for a specific individual, we filtered all DNA methylation probes with biological variation exceeded technical variation by sd~personal~(β) \> 0.01, resulting in 239566 -- 274864 candidate DNA methylation sites for the six subjects. By applying PeSa analysis, we found personalized synchronized DNA methylation sites for glucose, which showed the most significantly changed biochemical indicator during the mission ([Supplementary Table S7](#SM2){ref-type="supplementary-material"}). About 829 -- 1795 probes (0.35--0.74% of candidate probes) changes were found to have synchronized with glucose levels for the six individuals. For instance, probe cg18285788 (annotated in *PTPRN2)*, significantly synchronized with the glucose variation for subject S02 ([Figure 4B](#F4){ref-type="fig"}). Furthermore, glucose-synchronized probes were annotated in gene-related features and the probes on IGR were removed, then gene covered glucose-synchronized probes were sorted according to the most consistently found numbers for the subjects. Results showed that *PTPRN2*, *PRDM16*, *KCNQ1* and *COL11A2* are glucose-synchronized genes consistently found in all six subjects ([Table 2](#T2){ref-type="table"} and [Supplementary Table S8](#SM2){ref-type="supplementary-material"}). Then we performed functional annotation for the most glucose-synchronized methylation sites found in the six subjects (sorted by rho-value of traditional Pearson correlation). Results showed that, *type II diabetes mellitus* pathway *was* significantly enriched (*p* = 5.12e-4 for top-3000 genes, and *p* = 3.11e-3 for top-2000 genes) ([Table 3](#T3){ref-type="table"} and [Supplementary Tables S9](#SM2){ref-type="supplementary-material"}, [S10](#SM2){ref-type="supplementary-material"}).

![Personalized Epigenetic-phenotype Synchronization Analysis (PeSa). **(A)** Pipelines of Personalized Epigenetic-phenotype Synchronization Analysis. **(B)** Demonstration of glucose-sync DNAme site (cg18285788 at PTPRN2) for subject S02. Orange line: DNA methylation trend (beta-value). Red line: glucose trend. **(C)** Demonstration of TMD-sync DNAme site (cg20754430 at PTPRN2) for subject S02. Orange line: DNA methylation trend (beta-value). Red line: TMD trend.](fphys-10-00932-g004){#F4}

###### 

Glucose-synchronized and POMS-TMD-synchronized methylation sites found in PTPRN2 gene for six subjects.

  **Phenotype-sync probes (in PTPRN2)**   **Subjects**                                                       
  --------------------------------------- -------------- ------------ ------------ ------------ ------------ ------------
  Glucose-sync                            cg19803194     cg02306654   cg06018853   cg00720339   cg00369194   cg07624226
                                          cg05874166     cg11315900   cg16249010   cg02660277   cg05241143   cg27629384
                                          cg22960901     cg12211161                             cg06000610   
                                                         cg13909612                             cg07015608   
                                                         cg18285788                             cg10257673   
                                                         cg19744528                             cg24254317   
  POMS-TMD-sync                           cg16995768     cg05971373   cg01496696   cg18411660   cg16068431   cg03014997
                                          cg21280014     cg06018853   cg05064223   cg24998459   cg03071124   cg08401938
                                          cg24221919     cg07959864   cg07015608                cg04064735   cg09193477
                                                         cg11900120   cg07979652                cg04498153   cg12271047
                                                         cg20673767   cg08102838                cg04622731   cg13525062
                                                         cg20754430   cg09042009                cg04864538   cg23655400
                                                                      cg10471944                cg07267845   cg25566285
                                                                      cg21521989                cg09845489   cg01536803
                                                                      cg21608691                cg10288307   cg05171921
                                                                                                cg11251200   cg11517132
                                                                                                cg11900120   cg18411660
                                                                                                cg12144100   cg24093300
                                                                                                cg14178347   
                                                                                                cg14527439   
                                                                                                cg14706245   
                                                                                                cg20983647   
                                                                                                cg22213057   
                                                                                                cg22598247   
                                                                                                cg24688143   
                                                                                                cg25264630   
                                                                                                cg25481630   

For full analysis, see

Supplementary Table S8

.

###### 

KEGG pathway enrichment analysis for glucose-sync and POMS-TMD-sync genes.

  **KEGG pathway**                      **Glucose-sync genes**   **POMS-TMD-sync genes**                       
  ------------------------------------- ------------------------ ------------------------- ------------------- -----------------
  hsa04930:Type II diabetes mellitus    5.12e-4 (0.01)           3.11e-3 (0.059)           0.029 (0.15)        2.11e-3 (0.062)
  hsa04730:Long-term depression         --                       --                        1.92e-3 (0.025)     0.031 (0.237)
  hsa04022:cGMP-PKG signaling pathway   1.2e-3 (0.018)           3.82e-3 (0.068)           4.27e-4 (9e-3)      4.02e-3 (0.081)
  hsa04713:Circadian entrainment        2.8e-3 (0.024)           --                        9.61e-4 (0.014)     --
  hsa04611:Platelet activation          0.03 (0.16)              --                        9.38e-4 (0.015)     1.55e-3 (0.068)
  hsa05032:Morphine addiction           7.8e-3 (0.054)           --                        6.88e-5 (2.41e-3)   1.74e-3 (0.058)
  hsa04020:Calcium signaling pathway    1.47e-4 (0.005)          2.911e-4 (0.013)          0.018 (0.117)       --

Significance of pathway enrichment was shown as "

p

-value (Benjamini)" in this table. For full analysis, see

Supplementary Tables S11, S12

.

Considering that the crew exhibited a fluctuation of psychological adaptation similar to the third-quarter phenomenon during 520 days of confinement as previously reported ([@B37]), we also applied PeSa analysis for a mood state-related indicator POMS-TMD score. About 1018--11026 probes (0.41--4.52% of candidate probes) were found to be synchronized with and changed by POMS-TMD for the six individuals ([Supplementary Table S11](#SM2){ref-type="supplementary-material"}). For instance, probe cg20754430 (annotated in *PTPRN2)*, significantly synchronized with the POMS-TMD variation for subject S02 ([Figure 4C](#F4){ref-type="fig"}). By way of analyzing glucose-synchronized probes, we found *PTPRN2, MAD1L1, COL11A2, NFATC1*,*RPTOR*, and *TNXB* were POMS-TMD-synchronized genes which repeated in all six subjects ([Table 2](#T2){ref-type="table"} and [Supplementary Table S12](#SM2){ref-type="supplementary-material"}). Notably, *PTPRN2* covered both glucose- and POMS-TMD-synchronized probes in our finding. For most POMS-TMD-synchronized methylation sites found in the six subjects (sorted by rho-value of traditional Pearson correlation), functional annotation showed that the *long-term depression* pathway was significantly enriched (*p* = 1.92e-3 for top-3000 genes, and *p* = 0.031 for top-2000 genes). Additionally, we found that the *Circadian entrainment* pathway was also significantly enriched (*p* = 9.61e-4 for top-3000 genes) ([Table 3](#T3){ref-type="table"}). Evidence has shown that circadian disruption was found to be involved in psychiatric disorders ([@B16]), suggesting that mood-state fluctuation had an inseparable connection at least in part due to circadian disturbance in this study. Additionally, evidence based on a cell culture and depression-modeled animal study offers clues that several significantly enriched pathways have a certain relationship with long term depression, such as the cGMP-PKG signaling pathway (*p* = 4.27e-4 for top-3000 genes) ([@B17]; [@B43]), Platelet activation (*p* = 9.38e-4 for top-3000 genes) ([@B14]), Morphine addiction (*p* = 6.88e-5 for top-3000 genes) ([@B25]) and the Calcium signaling pathway (*p* = 0.02 for top-3000 genes) ([@B4]; [@B7]) ([Supplementary Tables S13](#SM2){ref-type="supplementary-material"}, [S14](#SM2){ref-type="supplementary-material"}).

Discussion {#S4}
==========

Our study offers a unique perspective on human adaptation to long-term isolation, compared to traditional case/control studies. We investigated the adaptation at phenotypic, biochemical and psychological levels in both a population and individual manner. While previous analyses of data in the Mars500 experiment have reported insights of psychiatric disorders ([@B37]), circadian disruptions ([@B2]), temporal dynamics of gut microbiota ([@B36]), immune responses ([@B40]), and physical-activity-related neuromuscular performance ([@B3]), this study was focused on individualized high frequency sampling for epigenetic profiling across the mission, and exploring the dynamic linking between DNA methylation changes and different aspect of phenotypes (POMS-TMD for mood-state, and glucose for metabolism).

First, we demonstrated a novel strategy to study the relationship between epigenetic signatures and phenotypes based on long-term epigenome-phenome tracking data sets and developed the PeSa analysis method, different than traditional population case/control studies. Interindividual variance, an unignored factor in both epigenomic and phenotypic research, was also deeply explored in popular studies, especially for the small size of the cohort. For instance, POMS-TMD score fluctuations showed significant distinction among subjects ([Supplementary Figure S5](#SM1){ref-type="supplementary-material"}). Additionally, a personalized analysis has received a lot of attention in previously reported studies of the Mars-500 experiment, such as circadian and gut microbiota ([@B2]; [@B36]). Intriguingly, in this study we developed a PeSa algorithm and traced temporal synchronous DNA methylation features, which refer to phenotypes from different aspects, including glucose for metabolism, and POMS-TMD for mood state. By applying the PeSa analysis, we could comprehensively discover the environmental-factor-induced inter-individual responses of the human body and find potential biomarkers. These are worth researching further, e.g., health risks, like metabolism or/and mood state disturbance, caused by long term isolation confinement.

Second, we found that global DNA methylation remodeling during long term isolation were evidence- supported. DMPs-associated genes were significantly enriched in *the Circadian entrainment pathway* during the mission, coinciding with previous studies which claimed that the majority of crew members experienced disturbances of sleep quality, vigilance deficits and altered sleep--wake periodicity and timing ([@B2]). Several glucose metabolism-related pathways were also significantly enriched, including *Type 2 diabetes mellitus* and *insulin signaling pathway.* Accordingly, we also found that the glucose level changed significantly during the mission. This finding is consistent with earlier studies, which show global changes in DNA methylation in association with glycemic metabolisms ([@B27]) and insulin resistance ([@B42]). It has also been reported that platelet activation is associated with DM and hyperglycemia ([@B34]; [@B35]). In this study, we found that DMPs-associated genes were significantly enriched in the *platelet activation pathway*, while plasma serotonin (5-HT), a platelet-stored vasoconstrictor ([@B6]), was also detected to be significantly changed. The association between platelet activation and major depressive disorder (MDD) was also reported in MDD patients vs. mentally healthy controls ([@B14]). Notably, though the long-term isolation in this study did not exert the subjects into disease-states like T2D or MDD patients, similar associations among glucose-metabolism, depression and platelet activation were found. It is interesting that we found these associations from an epigenetic perspective, suggesting that these associations not only exist in clinical studies, but might possibly also occur in the process of environmental-factor-induced glucose-metabolism and mood state disorder over millions of years of adaptation in human beings to the terrestrial environment.

Third, the specific gene, *PTPRN2*, was consistently found to cover DNA methylation sites synchronously changing with glucose and POMS-TMD across all six subjects in this study. *PTPRN2*, also known as IAR, has been identified as an autoantigen in insulin-dependent DM ([@B32]). Evidence also substantiates that *PTPRN2* was in genetic association with bipolar disorder in the GWAS study ([@B8]; [@B29]). Thus, in this study it is suggested that applying the PeSa analysis in a long-term epigenome-phenome tracking study could facilitate the discovery of biologically meaningful epigenetic signatures, which correlate with domain-crossing phenotypes, such as metabolism and mood state. Since the current study was limited in its sample size and the data set design, the verification of glucose- and POMS-TMD- synchronized DNA methylation signatures found in this study are necessary in additional long-term confinement studies, and the validation of the PeSa method is still required by applying studies based on a distinct population size, diverse environmental factors, and different time-scales of data samplings.

Conclusion {#S5}
==========

In this study, we conducted a personalized dynamic interrogation of the genome-wide DNA methylation profiling of six subjects at six sampling points during the Mars-520 simulated mission. We utilized mood state and plasma metabolic traits to investigate Psycho-Epigenome-Metabolism changes during adaptation to long-term isolation. Our findings suggest that epigenetic features could reflect the effects of long-term isolation on the human body, such as glucose and mood state disturbances. Genes with personalized phenotype-synchronized epigenetic features could reflect the dynamic adaptation process of human adaptation to extreme environmental changes.
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5-HT

:   5-hydroxytryptamine

ADI

:   adiponectin

AH

:   Anger-Hostility

CB

:   Confusion-Bewilderment

DD

:   Depression-Dejection

DM

:   Diabetes mellitus

DMP

:   differentially methylated probe

FDR

:   false discovery rate

FI

:   Fatigue-Inertia

HM450

:   Infinium Human Methylation 450 Bead Chip array platform

IFG

:   impaired fasting glucose

Interval-DMR

:   differentially methylated region in specific Interval

NE

:   norepinephrine

PeSa

:   Personalized Epigenetic-Phenotype Synchronization Analysis

POMS

:   Profile of Mood States

SNP

:   single nucleotide polymorphism

TA

:   Tension-Anxiety

UTR

:   untranslated region

VA

:   Vigor-Activity.
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